New York, August 22, 2022 – Accenture’s Life Sciences Technology Vision 2022 report explores technology trends that will shape how biopharmaceutical and medical technology companies solve product and device issues, improve equity in clinical trial participation and build more flexible supply chains to deliver to patients. And healthcare professionals with more personal experience.
The metaverse is a continuum evolving and expanding in multiple dimensions – digital and physical – that includes technologies including augmented reality, blockchain, artificial intelligence, digital twins, non-fungible tokens, and smart devices. According to the report, life science leaders (91% of medical technology executives and 85% of biopharma executives) expect Metaverse to have a positive impact on their organizations, and nearly half of biopharma executives surveyed believe Metaverse will have a breakthrough or transformative impact. in their organizations.
Petra Zantzer, global industry life sciences lead at Accenture, said, “We are in the early days of the metaverse, and the technology innovations we implement today – the solutions, products and services companies offer, how they develop and how they deliver them – fundamentally drive their organizations. — are the building blocks of the future for the life sciences. Industry leaders are pioneering a new digital future for how people and enterprises interact, and many rules are undefined. It is critical that life sciences companies proactively and responsibly take steps to shape the metaverse continuum.”
To help life sciences companies design, implement and accelerate their metaverse journeys, Accenture recently launched the Accenture Metaverse Continuum business group, which combines customer experience, digital commerce, augmented reality, blockchain, digital twin, metaverse-skilled professionals and market-leading capabilities. combines. Artificial intelligence, and computer vision.
In the report, four technology trends that underpin the Metaverse continuum are explored:
- WebMe How the Internet has been reimagined with the Metaverse as a platform for digital experiences that offer infinite places where people can meet and interact, and Web3 is reinventing how data can be owned by the person and moved with the person, not the platform. In the future, a new generation of digital devices will be integrated into the metaverse and may include smart technology in everyday objects such as household appliances, and ‘smart’ cars that provide key data on healthy human behaviors and medically regulated devices such as Donici. Can detect and analyze multiple bio-parameters simultaneously.
- The programmable world Tracks how technology is threaded into our physical environment at three levels: connected, experiential, and material. Nearly 9-in-10 of MedTech and biopharma executives surveyed believe physical environment programming will emerge as a competitive differentiator in their industry. Augmented reality, 5G, ambient computing, 3D printing, and smart materials are transforming in sophisticated ways, turning the physical world into a smart, customizable, and digitally programmable environment.
- Unreal Explores the “unreal” qualities that are becoming fundamental to artificial intelligence (AI), and even data, making the synthetic seem authentic. Synthetic data is being used to train AI models in ways that real-world data cannot or will not practically do. Synthetic data may represent patient datasets for use in research, training, or other applications. This realistic (yet unrealistic) data can be shared, while preserving the same statistical properties as confidentiality and privacy. It can be developed to accommodate increased diversity to combat bias, thus overcoming the shortcomings of real-world data. Biopharma (92%) and medtech (91%) executives report that their organizations depend on AI technologies to function effectively.
- The calculation of the impossible A new class of machines is emerging – quantum computing – stretching the boundaries of what computers can do. Problems once thought impossible to solve because they require computation, large, complex datasets are now within the realm of the possible. Almost all surveyed biopharma (94%) and MedTech (96%) executives agree that their organization is pivoting in response to unprecedented computational power becoming available.
The Life Sciences Technology Vision 2022 report can be accessed here.
Accenture is a global professional services company with leading capabilities in digital, cloud, and security. Combining unparalleled experience and specialized skills across more than 40 industries, we offer strategy and consulting, technology and operations services, and Accenture Song – all powered by the world’s largest network of advanced technology and intelligent operations centers. Our 710,000 people deliver on the promise of technology and human ingenuity, serving customers in more than 120 countries every day. We embrace the power of change to create value and shared success for our customers, people, shareholders, partners, and communities.